Search

Your search keyword '"Leroux D"' showing total 445 results

Search Constraints

Start Over You searched for: Author "Leroux D" Remove constraint Author: "Leroux D"
445 results on '"Leroux D"'

Search Results

2. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

6. S11.3 Low-dose interleukin-2 therapy in active systemic lupus erythematosus (lupil-2): a multi-center, double-blind, randomized and placebo-controlled phase 2 trial

8. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement

9. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort

10. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

11. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

12. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

13. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.

15. The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia

17. Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRβ-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique

18. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

19. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

20. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

21. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers.

22. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

23. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

24. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

25. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

26. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

34. An ontological foundation for ocular phenotypes and rare eye diseases

38. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

39. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

40. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

41. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources

44. ERN-EYE: the European Reference Network dedicated to European patients with Rare Eye Diseases

47. Oral contraceptive use and breast cancer risk: Retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study.

48. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources

49. Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

50. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

Catalog

Books, media, physical & digital resources